Clinical Trial

The Value of the Turkish Translation of the Four-Dimensional Symptom Questionnaire for Turkish-speaking Patients With Psychological Complaints and Language Barriers.

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Our objectives are to determine whether the 4DSQ is valuable for Turkish-speaking patients living in Belgium who face language barriers-meaning they are not fluent in Dutch or French-and have psychological complaints, and to provide better support within the primary healthcare system for general practitioners (GPs). We will use individual semi-structured interviews with GPs who applied the Turkish 4DSQ to diagnose only Turkish-speaking patients with mental health issues.
Trial Details
NCT Number NCT07653022
Lead Sponsor Universitair Ziekenhuis Brussel
Conditions Depression Anxiety Disorder
Enrollment 80 participants
Start Date 2025-10-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-17